Improved glucose-stimulated insulin secretion by intra-islet inhibition of protein-tyrosine phosphatase 1B expression in rats fed a high-fat diet

Journal of Endocrinological Investigation

Volumn 35, Issue 1, 2012, Pages 63-70

  Lu, B ^a   Wu, H ^b   Gu, P ^a   Du, H ^a   Shao, J ^a   Wang, J ^a   Zou, D ^b  

^a NANJING GENERAL HOSPITAL OF NANJING MILITARY COMMAND   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Glucose stimulated insulin secretion; Insulin resistance; Protein tyrosine phosphatase 1B

Indexed keywords

FAT; GLUCOKINASE; GLUCOSE; GLUCOSE TRANSPORTER 2; INSULIN; LIPID; PROTEIN TYROSINE PHOSPHATASE 1B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GLUCOSE INTOLERANCE; INSULIN RELEASE; LIPID DIET; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; RAT;

ANIMALS; BLOOD GLUCOSE; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; GLUCOSE; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MALE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; SWEETENING AGENTS;

EID: 84861971307     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7766     Document Type: Article

References (32)

1. McGarry JD, Dobbins RL. Fatty acids, lipotoxicity and insulin secretion. Diabetologia 1999, 42: 128-38. (Pubitemid 29064233)
2. Unger RH, Orci L. Diseases of liporegulation: new perspective on obesity and related disorders. Faseb J 2001, 15: 312-21. (Pubitemid 32141423)
3. Unger RH, Zhou YT. Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes 2001, 50 (Suppl 1): S118-21. (Pubitemid 32148232)
4. Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 2002, 32 (Suppl 3): 14-23. (Pubitemid 41704996)
5. Milbum JL, Hirose H, Lee YH, et al. Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. J Biol Chem 1995, 270: 1295-9.
6. Dobbins RL, Chester MW, Daniels MB, McGarry JD, Stein DT. Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans. Diabetes 1998, 47: 1613-8. (Pubitemid 28445350)
7. Ahmad F, Considine RV, Bauer TL, Ohannesian JP, Marco CC, Goldstein BJ. Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein-tyrosine phosphatases in adipose tissue. Metabolism 1997, 46: 1140-5. (Pubitemid 27418501)
8. Ahmad F, Azevedo JL, Cortright R, Dohm GL, Goldstein BJ. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. J Clin Invest 1997, 100: 449-58. (Pubitemid 27349093)
9. Gum RJ, Gaede LL, Heindel MA, et al. Antisense protein tyrosine phosphatase 1B reverses activation of p38 mitogen-activated protein kinase in liver of ob/ob mice. Mol Endocrinol 2003, 17: 1131-43. (Pubitemid 36683720)
10. Bento JL, Palmer ND, Mychaleckyj JC, et al. Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes. Diabetes 2004, 53: 3007-12. (Pubitemid 39425929)
11. Kipfer-Coudreau S, Eberlé D, Sahbatou M, et al. Single nucleotide polymorphisms of protein tyrosine phosphatase 1B gene are associated with obesity in morbidly obese French subjects. Diabetologia 2004, 47: 1278-84. (Pubitemid 39093324)
12. Gu P, Jiang W, Du H, Shao J, Lu B, Wang J, Zou D. Protein tyrosine phosphatase 1B gene polymorphisms and essential hypertension: a case-control study in Chinese population. J Endocrinol Invest 2010, 33: 483-8.
13. Zabolotny JM, Haj FG, Kim YB, et al. Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action. J Biol Chem 2004, 279: 24844-51. (Pubitemid 38725352)
14. Egawa K, Maegawa H, Shimizu S, et al. Protein-tyrosine phosphatase-1B negatively regulates insulin signaling in I6 myocytes and Fao hepatoma cells. J Biol Chem 2001, 276: 10207-11.
15. Elchebly M, Payette P, Michaliszyn E, et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1 B gene. Science 1999, 283: 1544-8.
16. Klaman LD, Boss O, Peroni OD, et al. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 2000, 20: 5479-89. (Pubitemid 30482885)
17. Rothenberg PL, Willison LD, Simon J, Wolf BA Glucose-induced insulin receptor tyrosine phosphorylation in insulin-secreting betacells. Diabetes 1995, 44: 802-9.
18. Harbeck MC, Louie DC, Howland J, Wolf BA, Rothenberg PL. Expression of insulin receptor mRNA and insulin receptor substrate 1 in pancreatic islet beta-cells. Diabetes 1996, 45: 711-7. (Pubitemid 26168581)
19. Gao Z, Konrad RJ, Collins H, Matschinsky FM, Rothenberg PL, Wolf BA. Wortmannin inhibits insulin secretion in pancreatic islets and beta-TC3 cells independent of its inhibition of phosphatidylinositol 3-kinase. Diabetes 1996, 45: 854-62. (Pubitemid 26225498)
20. Leibiger IB, Leibiger B, Moede T, Berggren PO. Exocytosis of insulin promotes insulin gene transcription via the insulin receptor/PI-3 kinase/p70 s6 kinase and CaM kinase pathways. Mol Cell 1998, 1: 933-8. (Pubitemid 128379078)
21. Xu GG, Gao ZY, Borge PD Jr, Wolf BA. Insulin receptor substrate 1-induced inhibition of endoplasmic reticulum Ca2+ uptake in beta-cells. Autocrine regulation of intracellular ca2+ homeostasis and insulin secretion. J Biol Chem 1999, 274: 18067-74.
22. Taylor SI. Deconstructing type 2 diabetes. Cell 1999, 97: 9-12. (Pubitemid 29165884)
23. Gorogawa S, Fujitani Y, Kaneto H, et al. Insulin secretory defects and impaired islet architecture in pancreatic beta-cell specific STAT3 knockout mice. Biochem Biophys Res Commun 2004, 319: 1159-70. (Pubitemid 38759533)
24. Milburn JL Jr, Hirose H, Lee YH, et al. Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. J Biol Chem 1995, 270: 1295-9.
25. Kurreck J. Antisense technologies. Improvement through novel chemical modifications. Eur J Biochem 2003, 270: 1628-44. (Pubitemid 36532522)
26. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411: 494-8. (Pubitemid 32494397)
27. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002, 296: 550-3. (Pubitemid 34408678)
28. Matschinsky FM. Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes 1996, 45: 223-41. (Pubitemid 26045806)
29. Unger RH. Diabetic hyperglycemia: link to impaired glucose transport in pancreatic beta cells. Science 1991, 251: 1200-5. (Pubitemid 21926211)
30. Guillam MT, Hümmler E, Schaerer E, et al. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking GLUT2. Nat Genet 1997, 17: 327-30. (Pubitemid 27475998)
31. Matschinsky FM, Glaser B, Magnuson MA. Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities. Diabetes 1998, 47: 307-15. (Pubitemid 28104189)
32. Terauchi Y, Sakura H, Yasuda K, et al. Pancreatic beta-cell-specific targeted disruption of glucokinase gene. Diabetes mellitus due to defective insulin secretion to glucose. J Biol Chem 1995, 270: 30253-6.